TRANSITION AGREEMENTTransition Agreement • July 8th, 2019 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledJuly 8th, 2019 Company Industry JurisdictionThis Transition Agreement (“Transition Agreement”) is entered into by and between William Annett (“Executive”) and OncoCyte Corporation. (the “Company”) on July 1, 2019 and confirms the agreement that has been reached with Executive in connection with the end of Executive’s employment by the Company.